AR
Alfresa Holdings Corporation
ARHCF · OTC
$14.00 +0.00% (+$0.00)
Market Cap ¥390.1B
P/E Ratio 14.24x
Div. Yield 3.17%
ROE -
Bulios Fair Price
$20.84
48.9% upside
Current Price
$14
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ARHCF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
96 /100
Cheap P/E 14.24x
EV/EBITDA 4.56x
P/B 0.81x
Growth
32 /100
Declining EPS growth 1.33%
Rev. growth 4.62%
Book val. growth 0.72%
Profitability
5 /100
Weak Gross margin 7.22%
Net margin 0.92%
FCF margin 0.49%
Quality
40 /100
Average ROIC 4.86%
ROA 1.90%
Asset turnover 2.06x
Debt
93 /100
Low Debt/Equity 0.07x
Current ratio 1.22x
Net debt/EBITDA -2.59x
Stability
72 /100
Stable Beta 0.08x
Rev. volatility 1.26%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ARHCF
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Ryuji Arakawa
Employees
12,525
Headquarters
Tokyo
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
05 NOV
Earnings
Upcoming earnings report
31 MAR
Ex-Dividend
Ex-dividend date
31 MAR
Dividend Payment
Payment date